Inclusion Criteria:  Any sex, aged ≥ 19 years Indication to undergo an operation with a planned pelvic incision Able and willing to provide informed consent Stated willingness to comply with all study procedures and availability for the duration of the study If sexually active, is willing to use adequate birth control methods to prevent pregnancy over the course of the study  Exclusion Criteria:  History of chronic pain conditions associated with the use of opioids or steroids Known allergic reactions to any components of the investigational product Active infection involving the surgical site Any contraindication to local anesthesia with lidocaine (e.g., known hypersensitivity to anesthetics of the amide type, known hypokalemia, complete heart block, anticoagulants (ASA permitted) antiarrhythmic medication) Use of prohibited medications (quinidine, procainamide, disopyramide, lidocaine, mexiletine, flecainide, propafenone, amiodarone, dronedarone, ibutilide, dofetilide, sotalol, vernakalant) Has participated in another clinical trial within 3 months prior to the Screening Visit or is planning to participate in another clinical trial during this trial period Has any other surgical or medical condition that, in the judgment of the clinical Investigator might warrant exclusion or be contraindicated for safety reason